Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis.

Literature DB >> 18715036

Viridamides A and B, lipodepsipeptides with antiprotozoal activity from the marine cyanobacterium Oscillatoria nigro-viridis.

T Luke Simmons¹, Niclas Engene, Luis David Ureña, Luz I Romero, Eduardo Ortega-Barría, Lena Gerwick, William H Gerwick.

Abstract

Parallel chemical and phylogenetic investigation of a marine cyanobacterium from Panama led to the isolation of two new PKS-NRPS-derived compounds, viridamides A and B. Their structures were determined by NMR and mass spectroscopic methods, and the absolute configurations assigned by Marfey's method and chiral HPLC analysis. In addition to six standard, N-methylated amino and hydroxy acids, these metabolites contained the structurally novel 5-methoxydec-9-ynoic acid moiety and an unusual proline methyl ester terminus. Morphologically, this cyanobacterium was identified as Oscillatoria nigro-viridis, and its 16S rDNA sequence is reported here for the first time. Phylogenetic analysis of these sequence data has identified O. nigro-viridis strain OSC3L to be closely related to two other marine cyanobacterial genera, Trichodesmium and Blennothrix. Viridamide A showed antitrypanosomal activity with an IC50 of 1.1 microM and antileishmanial activity with an IC50 of 1.5 microM.

Entities: CellLine Chemical Disease Mutation Species

Mesh：

Substances：

Year: 2008 PMID： 18715036 PMCID： PMC2656441 DOI： 10.1021/np800110e

Source DB: PubMed Journal: J Nat Prod ISSN： 0163-3864 Impact factor: 4.050

29 in total

Review 1. Nitrogen-containing metabolites from marine cyanobacteria.

Authors: W H Gerwick; L T Tan; N Sitachitta
Journal: Alkaloids Chem Biol Date: 2001

Review 2. Drug development for neglected diseases: a deficient market and a public-health policy failure.

Authors: Patrice Trouiller; Piero Olliaro; Els Torreele; James Orbinski; Richard Laing; Nathan Ford
Journal: Lancet Date: 2002-06-22 Impact factor: 79.321

3. The world's most neglected diseases.

Authors: Gavin Yamey; Els Torreele
Journal: BMJ Date: 2002-07-27

4. MEGA3: Integrated software for Molecular Evolutionary Genetics Analysis and sequence alignment.

Authors: Sudhir Kumar; Koichiro Tamura; Masatoshi Nei
Journal: Brief Bioinform Date: 2004-06 Impact factor: 11.622

5. Natural products chemistry and taxonomy of the marine cyanobacterium Blennothrix cantharidosmum.

Authors: Benjamin R Clark; Niclas Engene; Margaret E Teasdale; David C Rowley; Teatulohi Matainaho; Frederick A Valeriote; William H Gerwick
Journal: J Nat Prod Date: 2008-08-13 Impact factor: 4.050

6. Apramides A-G, novel lipopeptides from the marine cyanobacterium Lyngbya majuscula.

Authors: H Luesch; W Y Yoshida; R E Moore; V J Paul
Journal: J Nat Prod Date: 2000-08 Impact factor: 4.050

Review 7. Treatment perspectives for human African trypanosomiasis.

Authors: Bernard Bouteille; Odile Oukem; Sylvie Bisser; Michel Dumas
Journal: Fundam Clin Pharmacol Date: 2003-04 Impact factor: 2.748

8. Control of Chagas disease.

Authors:
Journal: World Health Organ Tech Rep Ser Date: 2002

9. Structure and biosynthesis of the jamaicamides, new mixed polyketide-peptide neurotoxins from the marine cyanobacterium Lyngbya majuscula.

Authors: Daniel J Edwards; Brian L Marquez; Lisa M Nogle; Kerry McPhail; Douglas E Goeger; Mary Ann Roberts; William H Gerwick
Journal: Chem Biol Date: 2004-06

Review 10. Visceral leishmaniasis: current status of control, diagnosis, and treatment, and a proposed research and development agenda.

Authors: Philippe J Guerin; Piero Olliaro; Shyam Sundar; Marleen Boelaert; Simon L Croft; Philippe Desjeux; Monique K Wasunna; Anthony D M Bryceson
Journal: Lancet Infect Dis Date: 2002-08 Impact factor: 25.071

16 in total

Review 1. Biologically active secondary metabolites from marine cyanobacteria.

Authors: Joshawna K Nunnery; Emily Mevers; William H Gerwick
Journal: Curr Opin Biotechnol Date: 2010-10-26 Impact factor: 9.740

2. Phylogeny-guided isolation of ethyl tumonoate A from the marine cyanobacterium cf. Oscillatoria margaritifera.

Authors: Niclas Engene; Hyukjae Choi; Eduardo Esquenazi; Tara Byrum; Francisco A Villa; Zhengyu Cao; Thomas F Murray; Pieter C Dorrestein; Lena Gerwick; William H Gerwick
Journal: J Nat Prod Date: 2011-07-13 Impact factor: 4.050

3. Trichormamides C and D, antiproliferative cyclic lipopeptides from the cultured freshwater cyanobacterium cf. Oscillatoria sp. UIC 10045.

Authors: Shangwen Luo; Hahk-Soo Kang; Aleksej Krunic; Wei-Lun Chen; Jilai Yang; John L Woodard; James R Fuchs; Sang Hyun Cho; Scott G Franzblau; Steven M Swanson; Jimmy Orjala
Journal: Bioorg Med Chem Date: 2015-05-01 Impact factor: 3.641

4. Underestimated biodiversity as a major explanation for the perceived rich secondary metabolite capacity of the cyanobacterial genus Lyngbya.

Authors: Niclas Engene; Hyukjae Choi; Eduardo Esquenazi; Erin C Rottacker; Mark H Ellisman; Pieter C Dorrestein; William H Gerwick
Journal: Environ Microbiol Date: 2011-04-07 Impact factor: 5.491

5. Phylogenetic inferences reveal a large extent of novel biodiversity in chemically rich tropical marine cyanobacteria.

Authors: Niclas Engene; Sarath P Gunasekera; William H Gerwick; Valerie J Paul
Journal: Appl Environ Microbiol Date: 2013-01-11 Impact factor: 4.792

6. Cytotoxic veraguamides, alkynyl bromide-containing cyclic depsipeptides from the marine cyanobacterium cf. Oscillatoria margaritifera.

Authors: Emily Mevers; Wei-Ting Liu; Niclas Engene; Hosein Mohimani; Tara Byrum; Pavel A Pevzner; Pieter C Dorrestein; Carmenza Spadafora; William H Gerwick
Journal: J Nat Prod Date: 2011-04-13 Impact factor: 4.050